Although CCR2 [14] and CCR5 [15] receptor blockade has shown positive results in animal models of RA, targeted CCR2 [16] and CCR5 [17], [18] blockade was not effective in RA patients. The gene discussed is CCR5; the disease is rheumatoid arthritis.